Sign in →

Test Code TULI Francisella tularensis Antibody, IgM and IgG, Technical Interpretation, Serum


Specimen Required


Only orderable as part of a profile. For more information see TULAB / Francisella tularensis Antibody, IgM and IgG, ELISA, Serum.


Secondary ID

605953

Useful For

Interpretation to aid in the diagnosis of tularemia caused by Francisella tularensis

Method Name

Only orderable as part of a profile. For more information see TULAB / Francisella tularensis Antibody, IgM and IgG, ELISA, Serum.

 

Technical Interpretation

Reporting Name

F. tularensis Interpretation

Specimen Type

Serum

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 7 days
  Frozen  30 days

Clinical Information

Francisella tularensis is a small, intracellular, coccobacillary gram-negative bacterium and is an obligate pathogen in animals and humans, primarily maintained in rabbits, hares, cats, ticks, and deerflies. F tularensis is found throughout North America and parts of Asia and, similar to Brucella species, is considered a potential agent of bioterrorism. Human infection with F tularensis usually occurs through inhalation of infected aerosols, ingestion of contaminated meat or water, handling of diseased or sick animals, or through the bite of an infected arthropod (eg, tick, deerflies).

 

Following a 3- to 5-day incubation period, the clinical manifestations of infection with F tularensis differ primarily depending on the site and route of infection. The most common form of disease is ulceroglandular (45%-80% of cases), which is associated with an arthropod (or animal) bite or another cause of skin barrier compromise. This leads to development of a painful papule that ultimately ulcerates allowing the bacterium to enter the lymphatic system. Glandular tularemia is similar in presentation to ulceroglandular disease; however, it lacks the ulceration and, more frequently, causes septicemia. Other, less frequent clinical manifestations include oculoglandular (Parinaud syndrome), oropharyngeal and gastrointestinal disease, and pneumonic or typhoidal tularemia.

 

Diagnostic testing options for F tularensis primarily include culture and serology. Providers suspecting tularemia should collect appropriate specimens (eg, skin lesion biopsy, lymph node aspirates) promptly and send for culture. The microbiology laboratory should be alerted to the possibility of F tularensis to ensure that appropriate safety measures are taken to protect the laboratory technologists. Growth on culture is a definitive means of making a diagnosis of tularensis. Serologic testing may be used to support a diagnosis of current or recent tularensis in patients who are IgM positive, who seroconvert to IgM, or who are IgG positive in paired sera collected 2 to 3 weeks apart.

Reference Values

Only orderable as part of a profile. For more information see TULAB / Francisella tularensis Antibody, IgM and IgG, ELISA, Serum.

 

IgM: Negative

IgG: Negative

 

Reference values apply to all ages.

Interpretation

IgM result

IgG result

Interpretation

Negative

Negative

No antibodies to Francisella tularensis detected. Antibody response may be negative in samples collected too soon following infection/exposure. Repeat testing on a new sample in 1 to 2 weeks if clinically indicated.

Positive

Negative

IgM class antibodies to F tularensis detected, suggesting current or recent infection. Repeat testing in 1 to 2 weeks to detect seroconversion of IgG may be considered to confirm the diagnosis.

Positive

Borderline

Borderline

Negative

Questionable presence of IgM antibodies to F tularensis. Consider repeat testing in 1 to 2 weeks.

Borderline

Positive

IgG class antibodies to F tularensis detected suggesting recent or past infection. Clinical correlation alongside presentation, exposure history and other laboratory findings required.

Borderline

Borderline

Questionable presence of IgM and IgG class antibodies to F tularensis. Consider repeat testing in 1 to 2 weeks.

Positive

Positive

IgM and IgG class antibodies to F tularensis detected suggesting current, recent or past infection. Cross-reactions may occur in patients with a current or prior Brucella infection. Clinical correlation alongside presentation, exposure history and other laboratory findings required.

Negative

Positive

IgG class antibodies to F tularensis detected suggesting recent or past infection. Clinical correlation alongside presentation, exposure history and other laboratory findings required.

Negative

Borderline

Questionable presence of IgG antibodies to F tularensis. Consider repeat testing in 1 to 2 weeks.

Cautions

False-negative results may occur in specimens collected too soon following symptom onset, prior to the development of a detectable immune response. Repeat testing on new specimens collected 2 to 4 weeks later may be helpful.

 

False-positive results may occur in patients previously or currently infected with Brucella species. Other less frequent causes of cross-reactivity that have been reported include prior infection with Yersinia, Salmonella, or Legionella species.

 

IgM-class antibodies may be detectable as soon as 1 week after symptom onset and may remain detectable for multiple years following resolution of disease in some individuals. Therefore, an IgM positive result may not indicate current or recent infection in some cases.

 

Multiple subspecies of Francisella tularensis, including F tularensis subspecies tularensis, F tularensis subspecies holarctica, and F tularensis subspecies novicida are found throughout the northern hemisphere, including in the United States. The IgM and IgG anti-F tularensis enzyme-linked immunosorbent assays used at Mayo Clinic Laboratories are based on the lipopolysaccharide (LPS) antigen of F tularensis. Although not directly tested, previous studies indicate that there are no antigenic differences between the LPS of F tularensis subspecies tularensis and the other subspecies. Therefore, these assays should not be used to differentiate between infection with the various F tularensis subspecies.

Clinical Reference

1. Petersen JM, Schriefer ME, Araj GE. Francisella and Brucella. In: Carroll KC, Pfaller MA, Landry ML, et al, eds. Manual of Clinical Microbiology. 12th ed. AMS Press; 2019

2. Nigrovic LE, Wingerter SL. Tularemia. Infect Dis Clin North Am. 2008;22(3):489-504. doi:10.1016/j.idc.2008.03.004

Method Description

Automated interpretation of IgM and IgG antibody results for Francisella tularensis.

Day(s) Performed

Tuesday, Thursday

Report Available

Same day/1 day

Performing Laboratory

Mayo Clinic Laboratories in Rochester

LOINC Code Information

Test ID Test Order Name Order LOINC Value
TULI F. tularensis Interpretation 93718-5

 

Result ID Test Result Name Result LOINC Value
TULI F. tularensis Interpretation 93718-5

Test Classification

Not Applicable